Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for 2 4, 5- t
Most Correlated Studies
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
- L1000 CMAP - T-cell ALL JURKAT cells treated with small molecule perturbagens
- GSK cancer cell line transcript profiling
Most Relevant Literature
- A mechanistic study of the photodegradation of herbicide 2,4,5-trichlorophenoxyacetic acid in aqueou…
- Degradation of 2,4-dichlorophenoxyacetic acid (2,4-D) and 2,4,5-trichlorophenoxyacetic acid (2,4,5-T…
- Characterization of 2,4-dichlorophenoxyacetic acid and 2,4,5-trichlorophenoxyacetic acid-degrading f…
- Degradation of 2,4,5-trichlorophenoxyacetic acid by a novel Electro-Fe(II)/Oxone process using iron …
- TCDD exposure estimation for workers at a New Zealand 2,4,5-T manufacturing facility based on serum …
Most Relevant Clinical Trials
- MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study
- Romidepsin, CC-486 (5-azacitidine), Dexamethasone, and Lenalidomide (RAdR) for Relapsed/Refractory T…
- Doxorubicin, CC-(486) (5-azacitidine), Romidepsin, and Duvelisib (hARD) for T-cell Lymphoma
- LCAR-T2C CAR-T Cells in Relapsed or Refractory CD4+ T Lymphocyte Tumor
- Antibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infa…
